valuation

Nvidia's CEO Huang argues recent software sell-off is excessive, highlighting PTC as attractive AI-enabled opportunity trading at 19.4x forward free cash flow.

Costco delivered 691% returns over 10 years, vastly outpacing S&P 500. Stock trades at 52.6 P/E despite membership-driven profitability and supplier leverage.

Trade Desk trades at 14.5x forward earnings after revenue growth slowed to 14% YoY. Potential OpenAI partnership could reignite growth.

Nu Holdings stock fell 15.6% in February despite 45% revenue growth and 131M customers, as investors fret over U.S. expansion strategy and macroeconomic risks.

Apple deployed $841B in buybacks since 2013, reducing shares 43.3%, but faces slowing device sales growth and 33x earnings valuation, raising questions about financial engineering versus genuine value creation.

CrowdStrike's ARR accelerates to $5.25B with 24% growth and net new ARR jumping 47%. Strong momentum tempered by expensive 17x forward P/S valuation.

SpaceX faces 81% probability of IPO announcement by August 2026, potentially raising $50 billion—history's largest offering.

Meta's 24% revenue growth and Microsoft's 39% Azure surge position both tech giants as attractive 2026 growth investments, trading at reasonable forward P/E multiples.

Palantir stock down 30% from $200 peak, but strong 70-80% growth rates and analyst forecasts support ~40% upside potential to previous highs.

Microsoft offers better value than Netflix despite recent losses, as it capitalizes on AI infrastructure demand with proven monetization paths versus Netflix's streaming competition.

Nvidia and Meta trade at forward P/E ratios below S&P 500 average, offering rare value opportunities for long-term AI and technology investors despite distinct risks.

Eli Lilly trades at expensive P/E of 44 with meager 0.6% dividend yield despite GLP-1 success. Merck offers better value at P/E 16 and 2.8% yield with 30+ year dividend track record.

Amazon, Ollie's Bargain Outlet, and Target emerge as retail growth opportunities through cloud computing dominance, acquisition-driven expansion, and strategic brand repositioning.

TransMedics surges 104% on organ transplant dominance and 32% growth, but 56x forward earnings premium and 25% short interest raise sustainability questions for 2026.

Caterpillar poised to benefit from reshoring, AI data centers, and power infrastructure demand in 2026, but elevated 37x P/E valuation raises caution for value investors.

Netflix rebounds to $100/share after failed Warner Bros. Discovery deal, posting 16% revenue growth. Analysts see $150 potential amid streaming competition.

Five Magnificent Seven tech stocks emerge as March buys: NVIDIA, Microsoft, Meta offer growth at fair valuations; Amazon, Alphabet command justified premiums. Tesla, Apple avoided.

Caterpillar emerges as unexpected AI infrastructure play via data center construction, surging electricity demand (200% jump expected), and manufacturing reshoring—though valuation reflects investor awareness.

$GRMN soared 25.4% in February on record quarterly earnings across all segments and strong 2026 guidance, bolstered by dividend hikes and share buybacks.

Nvidia trades at 22x forward earnings, matching Meta as second-cheapest Magnificent Seven stock, despite delivering 65% revenue growth and dominating AI infrastructure markets.